Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00126
|
|||||
| Drug Name |
Adenine
|
|||||
| Synonyms |
1,6-Dihydro-6-Imnopurine; 1,6-Dihydro-6-iminopurine; 1H-Purin-6-amine; 1H-Purin-6-amine (9CI); 1H-Purine, 6-amino; 2'-DEOXY-ADENOSINE-3'-5'-DIPHOSPHATE; 3,6-Dihydro-6-iminopurine; 4, Vitamin B; 6-Amino-1H-purine; 6-Amino-3H-purine; 6-Amino-7H-purine; 6-Amino-9H-purine; 6-Aminopurine; 7H-Purin-6-amine; 9H-Purin-6-amine; AD2; ADE; ALBB-005925; ANE; Adenin; Adenine (8CI); Adenine (JAN/USP); Adenine [JAN]; Adenine-8-14C; Adenine-ring; Adeninimine; B 4, Vitamin; Leuco-4; Leucon (TN); Pedatisectine B; Purine, 6; USAF CB-18; Vitamin B 4; Vitamin B4; Vitamin-B4
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Dietary shortage [ICD11:5B7Z] | Approved | [1] | |||
| Therapeutic Class |
Dietary supplement
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H5N5
|
|||||
| Canonical SMILES |
C1=NC2=NC=NC(=C2N1)N
|
|||||
| InChI |
InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)
|
|||||
| InChIKey |
GFFGJBXGBJISGV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 73-24-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 135.13 | Topological Polar Surface Area | 80.5 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-0.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10317179
,10322142
,10534154
,11341806
,11361989
,11364000
,11364970
,11366562
,11367532
,11369124
,11370094
,11371752
,11373133
,2101
,2102
,3135000
,3447
,5344002
,5385494
,540768
,584702
,585680
,589178
,610762
,7847102
,7885703
,7885710
,7885885
,8025117
,8025303
,8144939
,8150497
,820745
,822025
,823157
,823652
,823885
,825880
,826914
,827713
,828509
,828511
,830162
,830693
,830719
,830741
,830750
,832226
,836808
,841461
|
|||||
| ChEBI ID |
ChEBI:16708
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ANT3 | Transporter Info | Adenine nucleotide translocator 3 | Substrate | [2] | |
| References | ||||||
| 1 | Clofarabine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells. Mol Biol Cell. 2007 Nov;18(11):4681-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.